ACXP News and Press, Acurx Pharmaceuticals Inc. From 10/02/23

Acurx Pharmaceuticals Announces Successful Completion and Early Discontinuation of the Ibezapolstat Phase 2b Trial for Treatment of C. difficile Infection PR Newswire Based on observed aggregate blinded data the Company has determined that both treatments, ibezapolstat ...

Acurx Announces Presentation and Update of Its pol IIIC R&D Pipeline at the World Antimicrobial Resistance Scientific Congress Acurx Announces Presentation and Update of Its pol IIIC R&D Pipeline at the World Antimicrobial Resistance Scientific Congress PR Newswire ...

Acurx Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference September 11-13, 2023 PR Newswire STATEN ISLAND, N.Y. , Aug. 22, 2023 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinica...

2023-08-14 13:18:02 ET Acurx Pharmaceuticals, Inc. (ACXP) Q2 2023 Earnings Conference Call August 14, 2023 8:00 AM ET Company Participants Rob Shawah - CFO Dave Luci - President and CEO Conference Call Participants Ed Arce - HC. Wainwright Michael Oku...

2023-08-14 11:30:17 ET Acurx Pharmaceuticals press release ( NASDAQ: ACXP ): Q2 GAAP EPS of -$0.28. The Company ended the second quarter with cash totaling $9.1 million compared to $9.1 million as of December 31, 2022. For further details see: Acurx Pharmaceutica...

2023-08-14 07:25:38 ET Acurx Pharmaceuticals press release ( NASDAQ: ACXP ): Q2 GAAP EPS of -$0.28 misses by $0.07 . The company ended the second quarter with cash totaling $9.1 million compared to $9.1 million as of December 31, 2022. For further details see: ...

Acurx Pharmaceuticals, Inc. Reports Second Quarter 2023 Results and Provides Business Update PR Newswire STATEN ISLAND, N.Y. , Aug. 14, 2023 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage bio...

Acurx Pharmaceuticals to Discuss Second Quarter 2023 Financial Results and Provide Business Update PR Newswire STATEN ISLAND, N.Y. , July 24, 2023 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceu...

2023-07-07 15:00:36 ET Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week, or the Seeking Alpha earnings calendar ...

NEW YORK, July 07, 2023 (GLOBE NEWSWIRE) -- New to The Street , an FMW Media production, will air its corporate interviews, episodes 486 and 487, on Newsmax and the FOX Business Network . The Following Corporate interviews will air on Newsmax, episode 486, Saturd...